Introduction/objectives The objective of this study is to describe the treatment patterns and use of healthcare resources in a
cohort of Colombian patients with rheumatoid arthritis (RA) treated with biological disease-modifying antirheumatic dru
Use of healthcare resources in a cohort of rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs or tofacitinib
Audifarma |
| Tiempo de lectura: Min
- Tema: Farmacoepidemiología
- Autores: Jorge Enrique Machado-Alba, Manuel E. Machado-Duque, Andres Gaviria-Mendoza, Juan Manuel Reyes & Natalia Castaño Gamboa
- Idiomas: Inglés
- Palabras clave: Agentes antirreumáticos. Medicamentos biológicos. Fármacos antirreumáticos modificadores de la enfermedad. Coste sanitario. Artritis reumatoideAntirheumatic agents.
Machado-Alba, J.E., Machado-Duque, M.E., Gaviria-Mendoza, A. et al. Use of healthcare resources in a cohort of rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs or tofacitinib. Clin Rheumatol 40, 1273–1281 (2021). Enlace: https://doi.org/10.1007/s10067-020-05432-6
